TIL Q2 2024 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$14M

Net Income

-$15M

EPS (Diluted)

$-2.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$294M

Total Liabilities

$99M

Stockholders' Equity

$195M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$14M	-$21M	+32.6%
Net Income	-$15M	-$19M	+20.1%